United States · Series B startup

Who invested in Arch Oncology

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2019, from 1 source

Latest round
Series B, $50MMar 2019
Led by
Lightchain
Investors
4 (1 led)
See who backed them

The rounds

  1. Mar 2019
    Series B$50M

    Reported by Businesswire

Everyone who backed them

Lightchainno record of our own yet1round, led 1
RiverVestVC firm1round
Roche VenturesGrowth equity1round
3x5 PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Arch Oncology

Who invested in Arch Oncology?

Arch Oncology's investors include Lightchain, RiverVest, Roche Ventures and 3x5 Partners. Lightchain led its latest round.

How much has Arch Oncology raised?

Arch Oncology has raised $50M across 1 round since 2019.

When did Arch Oncology last raise?

Arch Oncology's most recent round was a Series B of $50M in Mar 2019, led by Lightchain.

What was Arch Oncology's biggest round?

Its most recent round, $50M in Mar 2019, is also its largest on record.

Who backed Arch Oncology first?

Arch Oncology's first round on record, in Mar 2019, was backed by Lightchain, RiverVest and Roche Ventures and 1 others.

What stage is Arch Oncology at?

Arch Oncology's latest named round is a Series B, in Mar 2019.

Where is Arch Oncology based?

Arch Oncology is based in the United States.

Who led Arch Oncology's rounds?

Lightchain led the Series B in 2019.

Companies like Arch Oncology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.